Apimeds Pharmaceuticals US, Inc. (APUS) — Cash & Equivalents
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.64M | +47270.6% |
| 2024 | $3.5K | -99.2% |
| 2023 | $410.5K | — |
| Fiscal Year | Cash & Equivalents | Change YoY |
|---|---|---|
| 2025 | $1.64M | +47270.6% |
| 2024 | $3.5K | -99.2% |
| 2023 | $410.5K | — |